Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07517796 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

I.V Papavrine for Labor Induction in Term PROM

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This prospective randomized controlled trial aims to evaluate whether intravenous administration of papaverine 12 hours after term PROM reduces the interval from membrane rupture to delivery and improves maternal and neonatal outcomes. Researchers will compare drug papaverine to a placebo
Trial Details
NCT Number NCT07517796
Lead Sponsor Western Galilee Hospital-Nahariya
Conditions
(from sponsor)		 Premature Rupture of Membranes
Related terms Premature Rupture of Fetal Membranes
Enrollment 110 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov